.RESEARCH EMPHASIZE.16 Oct 2024.
In the NIAGARA trial, the add-on of perioperative durvalumab to standard procedure for muscle-invasive bladder cancer strengthened event-free as well as generally survival, denoting a brand new treatment possibility for this problem.